Sign in
4

Changes in Ownership

Eledon Pharmaceuticals, Inc. Filed Acc 0001209191-14-059636

Director bought 362,500 shares at $15.00 ($5,437,500)

  • Director acquired 7,549,570 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Harrison Seth Loring Director 2014-09-22 Conversion +7,549,570 7,549,579 I: show line 1 in the form
Harrison Seth Loring Director 2014-09-22 Purchase +362,500 $15.00 $5,437,500 7,912,079 I: show line 2 in the form
Open-market purchases · 362,500 sh · avg $15.00 · $5,437,500

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Harrison Seth Loring Director 2014-09-22 Conversion · Series A Preferred Stock −4,500,000 0 I: show line 3 in the form
Harrison Seth Loring Director 2014-09-22 Conversion · Series B-1 Preferred Stock −798,067 0 I: show line 4 in the form
Harrison Seth Loring Director 2014-09-22 Conversion · Series B-2 Preferred Stock −644,786 0 I: show line 5 in the form
Harrison Seth Loring Director 2014-09-22 Conversion · Series C Preferred Stock −14,604,833 0 I: show line 6 in the form
Harrison Seth Loring Director 2014-09-22 Conversion · Series D-1 Preferred Stock −8,711,335 0 I: show line 7 in the form
Harrison Seth Loring Director 2014-09-22 Conversion · Series D-2 Preferred Stock −1,539,643 0 I: show line 8 in the form
Harrison Seth Loring Director 2014-09-22 Conversion · Series D-3 Preferred Stock −24,046,035 0 I: show line 9 in the form
Harrison Seth Loring Director 2014-09-22 Conversion · Series E Preferred Stock −24,199,308 0 I: show line 10 in the form
Loading xslF345X03/doc4.xml…